Clinical Trials · NCT07457424

Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)

Active Not RecruitingN/ASemaglutide (Investigational)
Phase
N/A
Recruitment status
Active Not Recruiting
Sponsor
University College Dublin
Enrollment
140
Start date
Feb 2022
Locations
1 site, Ireland
Primary endpoint
Energy Intake from Liquid Meal Consumption
View Semaglutide compound reference